Drug Shortage Report for ERWINASE

Last updated on 2018-08-13 History
Report ID 57204
Drug Identification Number 02237815
Brand name ERWINASE
Common or Proper name L-asparaginase
Company Name JAZZ PHARMACEUTICALS FRANCE SAS
Market Status CANCELLED POST MARKET
Active Ingredient(s) ASPARAGINASE
Strength(s) 10000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 3 mL vials (20 vials per carton)
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-07-30
Estimated end date 2018-08-10
Actual end date 2018-08-10
Shortage status Resolved
Updated date 2018-08-13
Company comments Unanticipated delay in the scheduled release of the next batch of product
Health Canada comments
Contact Address 84 QUAI CHARLES DE GAULLE CITY ONE
LYON, AUVERGNE-RHONE-ALPES
FRANCE 69006
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-08-13 French Compare
v3 2018-08-13 English Compare
v2 2018-08-01 French Compare
v1 2018-08-01 English Compare